Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

By Application

Tumor Marker Detection

Creative Biolabs provides a comprehensive range of recombinant antibodies of the key tumor for research processes and diagnostic assay developments for our clients.

The knowledge of metastasis, proliferative signaling, metabolism, inflammation, apoptosis is the focus of research. Hence, the identification of tumor markers using antibodies is widely used in cancer diagnostics and research. Tumor markers are proteins or antigens which are used to detect elevated in the body due to the presence of cancer. Elevated quantities of tumor markers in the blood, urine, stool, tumor tissue for cancer diagnosis and prognostic evaluation can be detected by the tumor marker-specific antibodies.

Discovering and detecting cancer cell signaling pathways and the cellular process will help us to find a link between its genotype and phenotype.